Lupin acquires diabetes brands ONDERO and ONDERO MET from Boehringer Ingelheim

Pallavi Madhiraju- August 19, 2023 0

In a strategic move to fortify its position in the pharmaceutical domain, global major Lupin Limited proclaimed its acquisition of coveted diabetes brands ONDERO and ... Read More